- Home
- VKTX vs AAPG Comparison
VKTX vs AAPG Comparison
Compare VKTX & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- AAPG
- Stock Information
- Founded
- VKTX 2012
- AAPG 2009
- Country
- VKTX United States
- AAPG China
- Employees
- VKTX N/A
- AAPG N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- VKTX Health Care
- AAPG Health Care
- Exchange
- VKTX Nasdaq
- AAPG Nasdaq
- Market Cap
- VKTX 3.5B
- AAPG 3.6B
- IPO Year
- VKTX 2015
- AAPG 2025
- Fundamental
- Price
- VKTX $23.09
- AAPG $38.95
- Analyst Decision
- VKTX Strong Buy
- AAPG Buy
- Analyst Count
- VKTX 12
- AAPG 1
- Target Price
- VKTX $87.50
- AAPG N/A
- AVG Volume (30 Days)
- VKTX 6.8M
- AAPG 11.3K
- Earning Date
- VKTX 10-22-2025
- AAPG 11-06-2025
- Dividend Yield
- VKTX N/A
- AAPG N/A
- EPS Growth
- VKTX N/A
- AAPG N/A
- EPS
- VKTX N/A
- AAPG N/A
- Revenue
- VKTX N/A
- AAPG $54,524,554.00
- Revenue This Year
- VKTX N/A
- AAPG N/A
- Revenue Next Year
- VKTX N/A
- AAPG $387.72
- P/E Ratio
- VKTX N/A
- AAPG N/A
- Revenue Growth
- VKTX N/A
- AAPG N/A
- 52 Week Low
- VKTX $18.92
- AAPG $16.50
- 52 Week High
- VKTX $81.73
- AAPG $48.45
- Technical
- Relative Strength Index (RSI)
- VKTX 32.25
- AAPG N/A
- Support Level
- VKTX $24.82
- AAPG N/A
- Resistance Level
- VKTX $26.50
- AAPG N/A
- Average True Range (ATR)
- VKTX 1.18
- AAPG 0.00
- MACD
- VKTX -0.20
- AAPG 0.00
- Stochastic Oscillator
- VKTX 2.47
- AAPG 0.00
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.